Strapps Walter 4
4 · Gemini Therapeutics, Inc. /DE · Filed Mar 3, 2021
Insider Transaction Report
Form 4
Strapps Walter
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-03-01+99,133→ 99,133 totalExercise: $15.60Exp: 2031-02-28→ Common Stock (99,133 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable over a period of four years from the Vesting Start Date, March 1, 2021, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, provided that as of each such date the Grantee remains in a business relationship with the Company.